Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Centessa Pharmaceuticals plc | 40,000 | reported | 20 Jun 2025 | tx 4+184,000 |
| Epizyme, Inc. | 0 | reported | 12 Aug 2022 | tx 5+150,000−25,696 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2025 | GRANT_AWARD | Centessa Pharmaceuticals plc | 40,000 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Centessa Pharmaceuticals plc | 48,000 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Centessa Pharmaceuticals plc | 48,000 | 0.00 USD | deriv |
| 12 Aug 2022 | OTHER | Epizyme, Inc. | 25,696 | — | |
| 30 Jun 2022 | GRANT_AWARD | Centessa Pharmaceuticals plc | 48,000 | 0.00 USD | deriv |
| 17 May 2022 | GRANT_AWARD | Epizyme, Inc. | 8,994 | 0.00 USD | |
| 17 May 2022 | GRANT_AWARD | Epizyme, Inc. | 41,006 | 0.00 USD | deriv |
| 16 Nov 2021 | GRANT_AWARD | Epizyme, Inc. | 16,702 | 0.00 USD | |
| 16 Nov 2021 | GRANT_AWARD | Epizyme, Inc. | 83,298 | 0.00 USD | deriv |